COVID-19 vaccine reactogenicity among participants enrolled in the GENCOV study

CONCLUSIONS: We provide evidence of relatively mild and short-lived reactions reported by participants who have received approved COVID-19 vaccines.PMID:38521677 | DOI:10.1016/j.vaccine.2024.03.030

Source: Vaccine - March 23, 2024 Category: Allergy & Immunology Authors: Gregory Morgan Selina Casalino Sunakshi Chowdhary Erika Frangione Chun Yiu Jordan Fung Elisa Lapadula Saranya Arnoldo Erin Bearss Alexandra Binnie Bjug Borgundvaag Laurent Briollais Marc Dagher Luke Devine Steven M Friedman Zeeshan Khan Chloe Mighton Koni Source Type: research